Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Ernesto Sparrelid to Aged, 80 and over

This is a "connection" page, showing publications Ernesto Sparrelid has written about Aged, 80 and over.

 
Connection Strength
 
 
 
0.633
 
  1. Jansson H, Taflin H, Björnsson B, Urdzik J, Hemmingsson O, Rystedt JL, Gilg S, Sandström P, Sparrelid E. Outcomes After Resection for Multiple Intrahepatic Cholangiocarcinoma-A National Population-Based Study. Ann Surg Oncol. 2026 Apr; 33(4):2917-2925.
    View in: PubMed
    Score: 0.097
  2. Villard C, Habib M, Nordenvall C, Nilsson PJ, Jorns C, Sparrelid E. Conversion therapy in patients with colorectal liver metastases. Eur J Surg Oncol. 2021 08; 47(8):2038-2045.
    View in: PubMed
    Score: 0.069
  3. Björnsson B, Hasselgren K, Røsok B, Larsen PN, Urdzik J, Schultz NA, Carling U, Fallentin E, Gilg S, Sandström P, Lindell G, Sparrelid E. Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study. Int J Surg. 2020 Mar; 75:60-65.
    View in: PubMed
    Score: 0.064
  4. Jansson H, Cornillet M, Björkström NK, Sturesson C, Sparrelid E. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort. Eur J Surg Oncol. 2020 05; 46(5):804-810.
    View in: PubMed
    Score: 0.063
  5. Nilsson T, Rasinski P, Sparrelid E, Tzortzakakis A, Tran TA, Smedby Ö, Axelsson R, Lubberink M, Holstensson M. Kinetic modelling of [68Ga]Ga-FAPI-46 PET in pancreaticobiliary lesions: distinguishing cancer from pancreatitis. Eur J Nucl Med Mol Imaging. 2026 Jul; 53(9):5549-5559.
    View in: PubMed
    Score: 0.025
  6. Holmberg M, Dall'Olio T, Marwa M, Hansen CP, Kleive DB, Nappo G, Shi L, Sandström P, Björk D, Hadesi P, De Rosa RV, Andersson B, Ansari D, Chikkala B, Todeschini L, Leseman C, Schuitema J, Lodewijks Y, Månsson C, Delis S, Berrevoet F, Giannone F, Xenaki S, Pando E, Bertrand C, Vasileiadis K, Kirchweger P, Ciulla C, Luchini C, Luyer M, Besselink MG, Marchegiani G, Pandanaboyana S, Tingstedt B, Sulpice L, Wennerblom J, Björnsson B, Balakrishnan A, Labori KJ, Burgdorf SK, Qadan M, Sparrelid E, Pea A, Hernandez-Barco YG, Salvia R, Ghorbani P. Survival After Pancreatic Resection for Intraductal Papillary Mucinous Neoplasm: Supporting Selective Surgery. United European Gastroenterol J. 2026 Apr; 14(3):e70199.
    View in: PubMed
    Score: 0.025
  7. Faseh L, Fruhling P, Taflin H, Lundmark Rystedt J, Williamsson C, Hemmingsson O, Björnsson B, Gerling M, Sparrelid E, Sandström P, Hasselgren K, Engstrand J. Real-world management of patients with simultaneously diagnosed synchronous liver and lung metastatic colorectal cancer - a national cohort study. Acta Oncol. 2026 Mar 12; 65:201-212.
    View in: PubMed
    Score: 0.024
  8. Aaquist T, Henriksen TV, Mariager Jakobsen LL, Fristrup CW, Pfeiffer P, de Stricker K, Sparrelid E, Moro CF, Mortensen F, Knudsen AR, Hamilton-Dutoit S, Kleeff J, Mortensen MB, Andersen CL, Detlefsen S. Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. Hum Pathol. 2026 Feb; 168:106024.
    View in: PubMed
    Score: 0.024
  9. Nebbia M, Villard C, Gilg S, Sparrelid E, Gerling M, Engstrand J. Sex-Associated Aspects of Referral, Resectability, and Survival in Patients with Colorectal Liver Metastases (CRLM): A Population-Based Single-Center Study of 1207 MDT-Referred Patients. Ann Surg Oncol. 2026 Mar; 33(3):2527-2538.
    View in: PubMed
    Score: 0.024
  10. Shibata Y, Jansson H, Kobayashi K, Yu W, Oba A, Ghorbani P, Ono Y, D'Souza MA, Sturesson C, Ito H, Sparrelid E, Inoue Y, Gilg S, Takahashi Y. Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience. Eur J Surg Oncol. 2026 01; 52(1):111159.
    View in: PubMed
    Score: 0.024
  11. Suljagic A, Swartling O, Henningson ES, Ansorge C, Gilg S, Sparrelid E, Ghorbani P. Postoperative Cholangitis After Pancreatoduodenectomy: A Frequent Late Complication Demanding Standardized Prevention and Treatment Protocols. Ann Surg Oncol. 2025 Dec; 32(13):10007-10016.
    View in: PubMed
    Score: 0.024
  12. Rangelova EB, Ghorbani P, Valente R, Tanaka K, Halimi A, Arnelo U, Segersvärd R, Sparrelid E, Del Chiaro M. Overcoming the technical challenge of venous resection with pancreatectomy: Which factors determine survival? Eur J Surg Oncol. 2025 08; 51(8):109629.
    View in: PubMed
    Score: 0.023
  13. Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, Löhr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
    View in: PubMed
    Score: 0.023
  14. Villard C, Widman L, Sparrelid E, Bergquist A, Hagström H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
    View in: PubMed
    Score: 0.022
  15. Coppola A, La Vaccara V, Farolfi T, Asbun HJ, Boggi U, Conlon K, Edwin B, Ferrone C, Jonas E, Kokudo N, Perez EM, Satoi S, Sparrelid E, Stauffer J, Zerbi A, Takemura N, Lai Q, Almerey T, Bernon M, Cammarata R, Djoumi Y, Gallagher T, Ghorbani P, Ginesini M, Hashimoto D, Kauffmann EF, Kleive D, Lluís N, González RM, Napoli N, Nappo G, Nebbia M, Ricchitelli S, Sahakyan MA, Yamamoto T, Coppola R, Caputo D. Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria. Int J Surg. 2024 Oct 01; 110(10):6092-6099.
    View in: PubMed
    Score: 0.022
  16. Nikolic S, Ghorbani P, Pozzi Mucelli R, Ghazi S, Baldaque-Silva F, Del Chiaro M, Sparrelid E, Verbeke CS, Löhr JM, Vujasinovic M. Surgery in Autoimmune Pancreatitis. Dig Surg. 2022; 39(1):32-41.
    View in: PubMed
    Score: 0.018
  17. Cornillet M, Jansson H, Schaffer M, Hertwig L, Berglin L, Zimmer CL, Johansson H, Ellis E, Isaksson B, Gonzalez-Galarza FF, Middleton D, Malmberg KJ, Sparrelid E, Björkström NK. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Gastroenterology. 2019 10; 157(4):1067-1080.e9.
    View in: PubMed
    Score: 0.015
  18. Björnsson B, Sparrelid E, Hasselgren K, Gasslander T, Isaksson B, Sandström P. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases. Scand J Surg. 2016 Sep; 105(3):158-62.
    View in: PubMed
    Score: 0.012
  19. Björnsson B, Sparrelid E, Røsok B, Pomianowska E, Hasselgren K, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. Eur J Surg Oncol. 2016 Apr; 42(4):531-7.
    View in: PubMed
    Score: 0.012
  20. Røsok BI, Björnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
    View in: PubMed
    Score: 0.012
  21. Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015 Jun; 17(6):529-35.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)